FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 1 filers reported holding FULCRUM THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71 | +1.4% | 15,900 | -25.0% | 0.00% | – |
| Q2 2023 | $70 | -32.7% | 21,200 | -41.9% | 0.00% | – |
| Q1 2023 | $104 | -90.5% | 36,461 | -75.8% | 0.00% | – |
| Q4 2022 | $1,095 | -99.7% | 150,509 | +237.4% | 0.00% | – |
| Q3 2022 | $361,000 | +147.3% | 44,605 | +50.1% | 0.00% | – |
| Q2 2022 | $146,000 | -75.5% | 29,717 | +17.9% | 0.00% | – |
| Q1 2022 | $596,000 | -75.0% | 25,205 | -81.3% | 0.00% | – |
| Q4 2021 | $2,384,000 | +90.3% | 134,755 | +203.5% | 0.00% | – |
| Q3 2021 | $1,253,000 | – | 44,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $32,054,000 | 14.00% |
| TRV GP IV, LLC | 2,343,154 | $18,956,000 | 11.08% |
| Logos Global Management LP | 1,950,000 | $15,776,000 | 1.94% |
| COWEN AND COMPANY, LLC | 2,347,989 | $18,995,000 | 1.82% |
| VR Adviser, LLC | 1,200,000 | $9,708,000 | 1.50% |
| RA Capital Management | 7,000,000 | $56,630,000 | 1.21% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,528,000 | $28,542,000 | 1.18% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $1,780,000 | 0.77% |
| RTW INVESTMENTS, LP | 3,985,910 | $32,246,000 | 0.74% |
| BRANDYWINE MANAGERS, LLC | 26,127 | $211,000 | 0.69% |